Expert Opinion on Drug Safety logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 8, Number 5, September 2009

< previous issue | all issues | next issue >

Original Research

Reviews

The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence
pp. 523-535(13)
Authors: Howgate, Daniel J; Gamie, Zakareya; Panteliadis, Pavlos; Bhalla, Amit; Mantalaris, Athanasios; Tsiridis, Eleftherios

Risk of venous thromboembolism due to antipsychotic drug therapy
pp. 537-547(11)
Authors: Hägg, Staffan; Jönsson, Anna K; Spigset, Olav

Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?
pp. 549-557(9)
Authors: Cancelli, Iacopo; Beltrame, Massimiliano; D'Anna, Lucio; Gigli, Gian Luigi; Valente, Mariarosaria

Diabetes medications and body weight
pp. 573-584(12)
Authors: Mitri, Joanna; Hamdy, Osama

The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke
pp. 585-597(13)
Authors: Kiphuth, Ines C; Köhrmann, Martin; Huttner, Hagen B; Schellinger, Peter D

Sodium nitroprusside induced cyanide toxicity in pediatric patients
pp. 599-602(4)
Authors: Thomas, Christopher; Svehla, Lindsay; Moffett, Brady S

Drug Safety Evaluation

Considerations on the use of oxymorphone in geriatric patients
pp. 603-613(11)
Authors: Pergolizzi, Joseph V; Raffa, Robert B; Gould, Errol

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page